Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Markets in ‘fear phase’, deploy money in autos, banks, capital goods: AlfAccurate’s Rajesh Kothari
The sharp correction in Indian equities triggered by fears of a prolonged war in West Asia should be viewed as a buying opportunity, according to Rajesh Kothari, Managing Director at AlfAccurate Advisors.Benchmark indices declined nearly 3% this week — their steepest weekly fall in over a year — as rising crude oil prices and geopolitical tensions rattled investor sentiment. Financial stocks led the decline, with the Nifty Bank logging its biggest weekly drop in 14 months.However, Kothari believes the selloff reflects sentiment rather than a deterioration in underlying economic fundamentals.“We are currently in a fearful phase of the market. When others are fearful, that’s usually the time to be greedy,” Kothari told CNBC-TV18, advising investors to deploy money gradually over the next 30–60 days rather than attempting to time the market.He emphasised that the outcome of the West Asia conflict is less important for markets than its duration. While companies with exposure to the Middle East could face short-term uncertainty, the broader domestic growth story remains intact.Against this backdrop, Kothari highlighted four sectors that investors should focus on.Autos remain a key bet, supported by strong demand trends and low inventory levels across the industry. February sales data was robust, and leading automakers have reported healthy growth, signalling sustained momentum.Banking and financials are another preferred sector. Credit growth has improved to around 13% from about 8.5% earlier, while asset quality remains strong. According to Kothari, the sector could become a “strong buy on declines” if crude-driven inflation concerns ease.He also sees opportunities in capital goods, particularly companies reporting strong order inflows as India’s investment cycle picks up.Lastly, hospitals stand out as a defensive play. The sector remains largely insulated from geopolitical risks and technological disruptions such as artificial intelligence.“These are strong India stori
Where is the Nifty headed next? Top CLSA chartist answers
The Nifty 50 index is down 1.6% so far in this truncated week and is set to decline in three out of the last four trading sessions, as the ongoing US-Iran war in West Asia, and the subsequent surge in oil prices have had a negative impact on market sentiment.
Vinay Rajani of HDFC Sec suggests HDFC Gold ETF, Oil India shares to buy in the near-term
The Indian stock market fell significantly on March 2, with the Sensex down 2,743 points and the Nifty 50 plummeting over 500 points due to geopolitical tensions and foreign capital withdrawals, resulting in a loss of ₹8 lakh crore in market capitalization.
Indian Stock Market Next Week (March 2-6, 2026): Sensex, Nifty to Trade Sideways Amid US, Israel-Iran Tension - Goodreturns
Indian Stock Market Next Week (March 2-6, 2026): Sensex, Nifty to Trade Sideways Amid US, Israel-Iran TensionGoodreturns
Nifty Pharma index soars 7% thus far in February; nears 52-week high
Thus far in the month of February 2026, Laurus Labs surged 13%, while Sun Pharmaceutical Industries and Torrent Pharmaceuticals soared 11% each.
Elara Securities bets on pharma revival; picks Zydus Life, Sun Pharma, Aurobindo Pharma
Bino Pathiparampil, Head of Research at Elara Securities believes the broader pharma space is entering a more favourable phase as pricing concerns and regulatory worries ease while currency movements provide an additional boost.
Sensex Today Ends Flat | Nifty Above 25,450 | Aditya Infotech Up 7% - Equitymaster
Sensex Today Ends Flat | Nifty Above 25,450 | Aditya Infotech Up 7%Equitymaster
Trade Setup for February 26: Nifty move beyond 25,300 - 25,700 range to determine next directional move
Despite surrendering a large part of its intraday gains on Wednesday, the Nifty managed to end higher, settling 57 points up at 25,782, though well off the day's peak.
Indian drugmaker Sai Life Sciences to boost headcount by about 20% amid global demand upswing
Sai Life Sciences will boost its workforce by over 700 employees next financial year. This expansion supports growing global demand for its services. The company is increasing capacity to meet this demand. New hires will focus on scientific, technical, and management roles. This move reflects a broader trend of global pharma companies expanding in India.
HDFC Life Insurance Company Ltd spurts 0.03%, up for five straight sessions
HDFC Life Insurance Company Ltd is quoting at Rs 733.4, up 0.03% on the day as on 12:44 IST on the NSE. The stock is up 17.75% in last one year as compared to a 12.33% gain in NIFTY and a 21.8% gain in the Nifty Financial Services.
Stock market today: Trade setup for Nifty 50, Gift Nifty, US-Iran war to gold, silver rates — 7 stocks to buy or sell
Stocks to buy today: Experts have recommended buying these eight shares — UPL, Biocon, HDFC Life, Fortis Healthcare, Tata Technologies, Samman Capital, and MM Forging
Kotak Nifty Next 50 ETF (KOTX) - Investing.com India
Kotak Nifty Next 50 ETF (KOTX)Investing.com India